1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Human Microbiome Sequencing Technology Revenue
1.4 Market Analysis by Type
1.4.1 Global Human Microbiome Sequencing Technology Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Traditional Sequencing Technologies
1.4.3 Next-Generation Sequencing
1.4.4 Third Generation Sequencing
1.5 Market by Application
1.5.1 Global Human Microbiome Sequencing Technology Market Share by Application: 2021-2026
1.5.2 Research and Academic Institutions
1.5.3 Pharmaceutical and Biotechnology Companies
1.5.4 Hospital and Clinic
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Human Microbiome Sequencing Technology Market
1.8.1 Global Human Microbiome Sequencing Technology Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Human Microbiome Sequencing Technology Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Human Microbiome Sequencing Technology Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Human Microbiome Sequencing Technology Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Human Microbiome Sequencing Technology Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Human Microbiome Sequencing Technology Sales Volume Market Share by Region (2015-2020)
3.2 Global Human Microbiome Sequencing Technology Sales Revenue Market Share by Region (2015-2020)
3.3 North America Human Microbiome Sequencing Technology Sales Volume
3.3.1 North America Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.3.2 North America Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Human Microbiome Sequencing Technology Sales Volume
3.4.1 East Asia Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.5.1 Europe Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.6.1 South Asia Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.7.1 Southeast Asia Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.8.1 Middle East Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.9.1 Africa Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.10.1 Oceania Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.11.1 South America Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.11.2 South America Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Human Microbiome Sequencing Technology Sales Volume (2015-2020)
3.12.1 Rest of the World Human Microbiome Sequencing Technology Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Human Microbiome Sequencing Technology Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Human Microbiome Sequencing Technology Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Human Microbiome Sequencing Technology Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Human Microbiome Sequencing Technology Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Human Microbiome Sequencing Technology Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Human Microbiome Sequencing Technology Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Human Microbiome Sequencing Technology Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Human Microbiome Sequencing Technology Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Human Microbiome Sequencing Technology Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Human Microbiome Sequencing Technology Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Human Microbiome Sequencing Technology Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Human Microbiome Sequencing Technology Sales Volume Market Share by Type (2015-2020)
14.2 Global Human Microbiome Sequencing Technology Sales Revenue Market Share by Type (2015-2020)
14.3 Global Human Microbiome Sequencing Technology Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Human Microbiome Sequencing Technology Consumption Volume by Application (2015-2020)
15.2 Global Human Microbiome Sequencing Technology Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Human Microbiome Sequencing Technology Business
16.1 Baseclear B.V.
16.1.1 Baseclear B.V. Company Profile
16.1.2 Baseclear B.V. Human Microbiome Sequencing Technology Product Specification
16.1.3 Baseclear B.V. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Novogene Corporation
16.2.1 Novogene Corporation Company Profile
16.2.2 Novogene Corporation Human Microbiome Sequencing Technology Product Specification
16.2.3 Novogene Corporation Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Clinical Microbiomics A/S
16.3.1 Clinical Microbiomics A/S Company Profile
16.3.2 Clinical Microbiomics A/S Human Microbiome Sequencing Technology Product Specification
16.3.3 Clinical Microbiomics A/S Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Beijing Genomics Institute (BGI) Genomics Co., Ltd
16.4.1 Beijing Genomics Institute (BGI) Genomics Co., Ltd Company Profile
16.4.2 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Technology Product Specification
16.4.3 Beijing Genomics Institute (BGI) Genomics Co., Ltd Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Illumina, Inc.
16.5.1 Illumina, Inc. Company Profile
16.5.2 Illumina, Inc. Human Microbiome Sequencing Technology Product Specification
16.5.3 Illumina, Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Charles River Laboratories International Inc.
16.6.1 Charles River Laboratories International Inc. Company Profile
16.6.2 Charles River Laboratories International Inc. Human Microbiome Sequencing Technology Product Specification
16.6.3 Charles River Laboratories International Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Oxford Nanopore Technologies, Inc.
16.7.1 Oxford Nanopore Technologies, Inc. Company Profile
16.7.2 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Technology Product Specification
16.7.3 Oxford Nanopore Technologies, Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 GENEWIZ, Inc.
16.8.1 GENEWIZ, Inc. Company Profile
16.8.2 GENEWIZ, Inc. Human Microbiome Sequencing Technology Product Specification
16.8.3 GENEWIZ, Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Eurofins Scientific SE
16.9.1 Eurofins Scientific SE Company Profile
16.9.2 Eurofins Scientific SE Human Microbiome Sequencing Technology Product Specification
16.9.3 Eurofins Scientific SE Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 OraSure Technologies, Inc.
16.10.1 OraSure Technologies, Inc. Company Profile
16.10.2 OraSure Technologies, Inc. Human Microbiome Sequencing Technology Product Specification
16.10.3 OraSure Technologies, Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Viome, Inc.
16.11.1 Viome, Inc. Company Profile
16.11.2 Viome, Inc. Human Microbiome Sequencing Technology Product Specification
16.11.3 Viome, Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Microba
16.12.1 Microba Company Profile
16.12.2 Microba Human Microbiome Sequencing Technology Product Specification
16.12.3 Microba Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Pacific Biosciences of California, Inc.
16.13.1 Pacific Biosciences of California, Inc. Company Profile
16.13.2 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Technology Product Specification
16.13.3 Pacific Biosciences of California, Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Molzym GmbH & Co. KG
16.14.1 Molzym GmbH & Co. KG Company Profile
16.14.2 Molzym GmbH & Co. KG Human Microbiome Sequencing Technology Product Specification
16.14.3 Molzym GmbH & Co. KG Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 CosmosID
16.15.1 CosmosID Company Profile
16.15.2 CosmosID Human Microbiome Sequencing Technology Product Specification
16.15.3 CosmosID Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Thermo Fisher Scientific Inc.
16.16.1 Thermo Fisher Scientific Inc. Company Profile
16.16.2 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Technology Product Specification
16.16.3 Thermo Fisher Scientific Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 QIAGEN N.V.
16.17.1 QIAGEN N.V. Company Profile
16.17.2 QIAGEN N.V. Human Microbiome Sequencing Technology Product Specification
16.17.3 QIAGEN N.V. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Microbiome Insights Inc.
16.18.1 Microbiome Insights Inc. Company Profile
16.18.2 Microbiome Insights Inc. Human Microbiome Sequencing Technology Product Specification
16.18.3 Microbiome Insights Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Leucine Rich Bio Pvt. Ltd.
16.19.1 Leucine Rich Bio Pvt. Ltd. Company Profile
16.19.2 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Technology Product Specification
16.19.3 Leucine Rich Bio Pvt. Ltd. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 Second Genome, Inc.
16.20.1 Second Genome, Inc. Company Profile
16.20.2 Second Genome, Inc. Human Microbiome Sequencing Technology Product Specification
16.20.3 Second Genome, Inc. Human Microbiome Sequencing Technology Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Human Microbiome Sequencing Technology Manufacturing Cost Analysis
17.1 Human Microbiome Sequencing Technology Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Human Microbiome Sequencing Technology
17.4 Human Microbiome Sequencing Technology Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Human Microbiome Sequencing Technology Distributors List
18.3 Human Microbiome Sequencing Technology Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Human Microbiome Sequencing Technology (2021-2026)
20.2 Global Forecasted Revenue of Human Microbiome Sequencing Technology (2021-2026)
20.3 Global Forecasted Price of Human Microbiome Sequencing Technology (2015-2026)
20.4 Global Forecasted Production of Human Microbiome Sequencing Technology by Region (2021-2026)
20.4.1 North America Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.3 Europe Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.7 Africa Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.9 South America Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Human Microbiome Sequencing Technology Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Human Microbiome Sequencing Technology by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.2 East Asia Market Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.3 Europe Market Forecasted Consumption of Human Microbiome Sequencing Technology by Countriy
21.4 South Asia Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.5 Southeast Asia Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.6 Middle East Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.7 Africa Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.8 Oceania Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.9 South America Forecasted Consumption of Human Microbiome Sequencing Technology by Country
21.10 Rest of the world Forecasted Consumption of Human Microbiome Sequencing Technology by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer